众安在线(06060.HK)转换H股获联交所授出上市批准
格隆汇 11 月 24日丨众安在线(06060.HK)发布公告,公司已向联交所上市委员会申请批准9.5亿股H股(转换H股,即根据转换并上市的被转换内资股的最高数目)上市及买卖。联交所已于2020年11月23日授出上市批准。
公司亦正就转换并上市开展以下工作:(i)给予公司的H股股份过户登记处关于转换H股的相关股票的指示;及(ii)促使转换H股获香港中央结算有限公司接纳为合资格证券,以于中央结算及交收系统作寄存、结算及交收。
预期转换H股的股票将于2020年12月10日发出予香港结算,而转换H股将于2020年12月11日上午九时正开始在联交所上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.